In this respect, the only described GD3S inhibitor, triptolide, a natural compound isolated from the Chinese herbal plant Tripterygium wilfordii, has shown promising therapeutic effects in breast cancer, pancreatic cancer, prostate cancer, and bladder cancer. Here, ST8SIA1 is linked to prostate cancer.